"Antibodies, Monoclonal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies produced by a single clone of cells.
Descriptor ID |
D000911
|
MeSH Number(s) |
D12.776.124.486.485.114.224 D12.776.124.790.651.114.224 D12.776.377.715.548.114.224
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Monoclonal".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Monoclonal".
This graph shows the total number of publications written about "Antibodies, Monoclonal" by people in this website by year, and whether "Antibodies, Monoclonal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 6 | 9 |
1996 | 1 | 8 | 9 |
1997 | 7 | 11 | 18 |
1998 | 4 | 7 | 11 |
1999 | 4 | 5 | 9 |
2000 | 6 | 8 | 14 |
2001 | 4 | 12 | 16 |
2002 | 7 | 18 | 25 |
2003 | 6 | 15 | 21 |
2004 | 6 | 9 | 15 |
2005 | 13 | 12 | 25 |
2006 | 13 | 7 | 20 |
2007 | 12 | 12 | 24 |
2008 | 18 | 16 | 34 |
2009 | 19 | 8 | 27 |
2010 | 18 | 7 | 25 |
2011 | 18 | 15 | 33 |
2012 | 7 | 11 | 18 |
2013 | 12 | 10 | 22 |
2014 | 17 | 8 | 25 |
2015 | 18 | 12 | 30 |
2016 | 21 | 12 | 33 |
2017 | 31 | 14 | 45 |
2018 | 36 | 7 | 43 |
2019 | 21 | 11 | 32 |
2020 | 16 | 21 | 37 |
2021 | 20 | 19 | 39 |
2022 | 4 | 20 | 24 |
2023 | 8 | 14 | 22 |
2024 | 10 | 8 | 18 |
2025 | 12 | 4 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Monoclonal" by people in Profiles.
-
Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations. Sci Adv. 2025 Sep 12; 11(37):eadx3505.
-
Identification of cobra and viper bites in southern India using enzyme-linked immunosorbent assay. Lab Med. 2025 Sep 08; 56(5):478-483.
-
Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine. Cell Rep. 2025 Aug 26; 44(8):116098.
-
A novel approach for quantifying therapeutic monoclonal antibodies in blood through liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2025 Oct 15; 1371:344427.
-
Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials. Contemp Clin Trials. 2025 Oct; 157:107995.
-
Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment. PLoS One. 2025; 20(6):e0325561.
-
Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi. Mol Ther. 2025 Sep 03; 33(9):4175-4192.
-
Pan-H7 influenza human antibody virus neutralization depends on avidity and steric hindrance. JCI Insight. 2025 Jul 08; 10(13).
-
Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer's Disease Dementia. Clin Nucl Med. 2025 Aug 01; 50(8):756-757.
-
Epitope mapping of SARS-CoV-2 Spike protein using naturally-acquired immune responses to develop monoclonal antibodies. Sci Rep. 2025 May 09; 15(1):16269.